发明名称 |
Mesothelin antibodies and methods for eliciting potent antitumor activity |
摘要 |
<p>Described herein is the use of phage display antibody engineering technology and synthetic peptide screening to identify SDl and SD2, human single-domain antibodies to mesothelin. SDl recognizes a conformational epitope at the C-terminal end (residues 539-588) of human mesothelin close to the cell surface. SD2 binds full-length mesothelin. To investigate SDl as a potential therapeutic agent, a recombinant human Fc (SDl-hFc) fusion protein was generated. The SDl-hFc protein exhibits strong complement-dependent cytotoxicity (CDC), in addition to antibody- dependent cellular cytotoxicity (ADCC), against mesothelin-expressing tumor cells. Furthermore, the SDl-hFc protein causes significant tumor growth inhibition of tumor xenografts in nude mice. SDl and SD2 are the first human single-domain antibodies targeting mesothelin-expressing tumors.</p> |
申请公布号 |
AU2013324049(A1) |
申请公布日期 |
2015.03.19 |
申请号 |
AU20130324049 |
申请日期 |
2013.09.16 |
申请人 |
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY |
发明人 |
HO, MITCHELL;PASTAN, IRA H.;DIMITROV, DIMITER S.;TANG, ZHEWEI;FENG, MINGQIAN;GAO, WEI |
分类号 |
C07K16/30;A61K39/395;A61P35/00 |
主分类号 |
C07K16/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|